Related Experiment Video
Updated: Jun 23, 2026
06:38
Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
Guidelines for drug therapy in renal failure
Annals of Internal Medicine
|June 1, 1977
Summary
This study offers drug dosage guidelines for patients with renal insufficiency, using medical literature and pharmacokinetic data. It highlights potential nephrotoxicity and suggests dialysis adjustments for safe and effective renal drug therapy.
Area of Science:
- Pharmacology
- Nephrology
- Clinical Pharmacy
Background:
- Renal insufficiency presents challenges in drug therapy due to altered pharmacokinetics.
- Managing drug dosages in patients with kidney disease requires careful consideration of drug properties and renal function.
Purpose of the Study:
- To provide evidence-based guidelines for drug selection and dosing in patients with renal insufficiency.
- To address the lack of specific drug information by utilizing pharmacokinetic principles.
- To highlight potential nephrotoxicity and offer recommendations for patients undergoing dialysis.
Main Methods:
- Systematic review of current medical literature.
- Analysis of pharmacokinetic variables for drugs lacking specific renal dosing data.
- Identification and documentation of nephrotoxic adverse effects.
Main Results:
- Five comprehensive tables detailing drug usage guidelines for renal insufficiency.
- Recommendations for drug therapy adjustments based on pharmacokinetic data.
- Noted nephrotoxicity of specific drugs in patients with renal disease.
Conclusions:
- The presented tables serve as a valuable resource for clinicians managing drug therapy in renal insufficiency.
- Emphasis on pharmacokinetic principles aids in rational drug selection and dosing.
- Consideration of dialysis and potential nephrotoxicity is crucial for patient safety.
Related Concept Videos
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:20Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...